Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EAU 2020 | EUPROMS: prostate cancer patient-driven QoL

André Deschamps • 18 Jul 2020
EAU 2020
Genitourinary Cancer Prostate Cancer

André Deschamps, of Europa Uomo, Antwerpen, Belgium, discusses the effect of prostate cancer treatment as evaluated in the EUPROMS study, the first ever patient driven quality of life (QoL) study. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

More from André Deschamps

0:58
The Europa Uomo advocacy movement
André Deschamps • 18 Jul 2020

Related Videos

4:05
Evaluating triplet therapy in metastatic hormone sensitive prostate cancer
Nick James • 24 Apr 2024
10:42
Management of prostate cancer from the patient perspective
David Matheson • 11 Apr 2024
2:26
Prognostic factors of renal cell cancer in elderly patients
Teemu Murtola • 9 Apr 2024
2:44
The effect of hypoxia on lipid metabolism and prostate cancer tumor growth
Teemu Murtola • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals